Redeemer Health

Redeemer Health

Redeemer Health traces its roots to 1924, when the Sisters of the Redeemer established a healthcare ministry that has since scaled into an integrated delivery network spanning acute care, home health, hospice, skilled nursing, and senior-living communities. The system remains sponsored by the religious congregation, with CEO Gregory T. Wozniak and Board Chairman William Sasso, a partner at Stradley Ronon who also serves on the board of the Greater Philadelphia Chamber of Commerce, providing secular governance continuity. The system allocates capital across three tightly linked verticals: hospital operations, senior-living real estate, and home-based care. Its flagship campus in Meadowbrook anchors Holy Redeemer Hospital, a 1648 Huntingdon Pike facility, alongside St. Joseph Manor and Redeemer Village. Additional senior-living assets include The Lafayette and The Villages at Pine Valley, while home-care and hospice services extend the catchment into New Jersey. In January 2023, Redeemer and Temple Health formed a joint venture to acquire Chestnut Hill Hospital, a move that kept the city facility operating and added a third Philadelphia campus. Confirmed clinical partnerships include an oncology co-brand with MD Anderson Cancer Center at Cooper. The organization maintains roughly a half-dozen owned properties concentrated in Huntingdon Valley and Northeast Philadelphia, plus a housing asset in Darby. Beyond delivery sites, the system supports two philanthropic entities — the Drueding Center, which addresses housing and family stability, and the Redeemer Health Foundation — though neither functions as a grant-making endowment in the traditional family-office sense. In February 2025, the system announced Heart Failure Certification at St. Joseph Manor and The Lafayette, signaling ongoing clinical investment in its post-acute portfolio. The structural differentiator resides in the permanent sponsorship by the Sisters of the Redeemer, which locks the system into a non-distributive, mission-held asset base. Unlike health systems accountable to shareholders or private-equity owners, Redeemer reinvests operating surpluses into contiguous care expansion and property improvement. The January 2023 Chestnut Hill joint venture with Temple Health tested whether the sponsorship model can absorb a distressed urban hospital without diluting the core real estate focus — two years in, the configuration holds.